Press Releases

Family Medicine specialists use AI to save the sight of diabetic patients

QUINCY, Ill., Nov. 21, 2019 /PRNewswire-PRWeb/ — The danger of diabetes-related blindness is becoming clearer to patients of Blessing Physician Services (BPS) a member of the Blessing Health System in Quincy, Illinois, thanks to Artificial Intelligence (AI) technology.

Diabetic retinopathy, a preventable condition caused by poorly controlled blood sugar, is the leading cause of blindness in the working age population.

“Patients don’t see an eye care specialist on a routine basis, as is recommended for all diabetics,” said Timothy Beth, DO, Family Medicine, BPS.

BPS is a multi-disciplinary group practice of more than 200 providers serving patients in west central Illinois, northeast Missouri and southeast Iowa. It is part of Blessing Health System and has joined an elite group of providers nationwide using AI to close the gap in diabetic eye exam compliance and detect diabetic retinopathy in its early, most treatable stage.

The new technology was created by IDx. The system is called IDx-DR. Using a robotic camera, a BPS medical assistant takes two images of each eye. The four images are immediately analyzed by the IDx algorithm to look for evidence of diabetic retinopathy. The process takes less than 10 minutes.

IDx-DR makes a clinical assessment without the need for a doctor to interpret the image or results. It is the first autonomous AI diagnostic system cleared by the FDA.

“The company has done well in developing an algorithm that can detect the possibility of early disease,” added Dr. Beth. “We would be missing patients if we did not use it.”

BPS placed its IDx-DR system in the Family Medicine Department to make eye screening more convenient for patients as a part of their routine medical care..

“After I see the patient, if they qualify for it or if they don’t have an eye doctor, we do the screening and get immediate results,” Dr. Beth explained. “If there is any evidence of retinopathy, we refer them to an eye doctor. If there is no evidence of retinopathy, we’ll do it again next year.”

Recognizing the potential of AI in the healthcare setting, a team led by Irshad Siddiqui, MD, Chief Health Information Officer, Blessing Health System, examined working with IDx.

“We found a good match with their mission and our mission,” he said.

“Blessing builds services on a foundation that includes convenient access to care and partnering with patients to enhance wellness,” said Maureen Kahn, RN, MHA, MSN, President/Chief Executive Officer, Blessing Health System. “IDx and its new technology delivers both of those benefits to our patients and their providers.”

In the first month of use, Dr. Siddiqui says one in every four patients undergoing the IDx-DR scan at Blessing has had a positive result for more than mild retinopathy.

“It gives us an idea of the disease burden of diabetic retinopathy within our population,” he concluded.

For a small percentage of people, those whose eyes don’t dilate well naturally or who have cataracts, IDx-DR may not capture a clear image for assessment. But for the majority of patients, Kristy Shepherd, medical office assistant, BPS, who conducts IDx-DR screenings, says results can be life-changing.

“I know we’ve found something that they probably were not going to find for some time if we were not offering the screening,” Shepherd said. “That’s a great thing.”

About Blessing Health System: Based in Quincy, Illinois, Blessing Health System consists of two hospitals, two multi-disciplinary provider groups, a health professions college, a charitable foundation, a company that markets medical equipment and supplies to the public and services to healthcare providers, and a parent company that provides business expertise and strategic planning to system affiliates.

About IDx: IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. Founded in 2010 by a team of world-renowned clinician scientists, the company is focused on developing clinically-aligned autonomous AI that detect disease in medical images. By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection.

 

SOURCE Blessing Health System

Europe’s Building Automation Systems Market, 2018-2019 & 2025F – Innovation Scouting, IoT-enabled Solutions, Intelligent PAAS Solutions & Integration of Product Lines Present Growth Opportunities

DUBLIN, Nov. 21, 2019 /PRNewswire/ — The “European Building Automation Systems (BAS) Market, Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The European building automation systems (BAS) market is poised to grow at a moderate CAGR of 2.6% from 2018 to 2025.

The key factors for growth are energy-efficiency requisites aiding BAS adoption and European and national regulatory plans led by Energy Performance of Buildings Directive (EPBD) and Energy Efficiency Directive (EED) to boost the energy performance of buildings and help the EU reach its 20% energy efficiency target by 2020. The regulatory push will reinforce governments to adopt possible strategies to improve energy efficiency at all stages of the energy chain.

The European Commission has proposed an update to EED including a 30% energy-efficiency target by 2030 and binding renewable energy target of 32% by 2030. These regulatory drivers will have a direct impact on the BAS market throughout the forecast period. Brownfield and greenfield opportunities for the new and existing building stock and transformational technologies such as artificial intelligence, machine learning, the Internet of Things (IoT), data analytics, and the cloud are also likely to drive the BAS and building energy management markets.

The European Commission estimates that the European building stock’s energy needs account for approximately 40% of the total energy generated in Europe. The building stock’s energy-intensive nature is a prime motive supporting the development of a smarter and more efficient building infrastructure for which BAS is considered a prerequisite asset.

The market has been transitioning from the traditional BAS with the core control and automation of heating, ventilation, and air conditioning (HVAC) to encompassing intelligent networking of all systems in buildings such as lighting, fire, access and safety, and facilities management. The main aim is to seamlessly integrate them to overall building management and optimization. The main evolution is in buildings being smarter, interactive, and energy-efficient. Occupancy comfort is the main focus of building automation and energy management.

The convergence of technologies will continue to change the market dynamics of the BAS market by reducing operating and infrastructure costs and improving the financial optimization of buildings.

Research Scope

The study includes revenue forecasts at a European and regional level, market drivers and restraints, technology trends, application market forecasts, channel analysis, competitive analysis, and identification of growth opportunities. The regional analysis breaks the market into Germany, the UK, Italy, Iberia, France, Benelux, Nordics, and the Rest of Europe.

Research Highlights

The study assesses and discusses the companies that performed well in 2018 and regulatory and construction trends at a regional level and key end-user segments. Some companies considered for the study include Siemens, Honeywell, Johnson Controls, Schneider Electric, Kieback& Peter, Sauter, Regin Controls, and Priva.

Key Issues Addressed

  • Is the market growing? How long will it continue to grow and at what rate? What are the risks and uncertainties affecting growth?
  • Which application market is growing? How long will it continue to grow and at what rate?
  • What are the various factors affecting the pricing of the controller and BAS software in the European BAS market and pricing trends?
  • What are the sales channels adopted in the European BAS market?
  • What are the factors influencing the growth of the BAS market across various regions in Europe and to what extent?
  • What is the competitive landscape of the European BAS market?

Companies Mentioned

  • Honeywell
  • Johnson Controls
  • Kieback & Peter
  • Priva
  • Regin Controls
  • Sauter
  • Schneider Electric
  • Siemens

Key Topics Covered

1. Executive Summary

  • Key Findings
  • Key Findings – Emerging Technology Roadmap
  • Market Engineering Measurements
  • CEO’s Perspective

2. Market Overview

  • Market Overview
  • Market Definitions
  • Key Questions this Study will Answer
  • BAS Communication Protocols
  • Market Segmentation by Application
  • Market Segmentation by Region
  • Market Distribution Channels
  • BAS Route to Market

3. Drivers and Restraints – Total BAS Market

  • Market Drivers
  • Drivers Explained
  • Market Restraints
  • Restraints Explained

4. Forecast and Trends – Total BAS Market

  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Percent Revenue Forecast by Region
  • Revenue Forecast by Region
  • Percent Revenue Forecast by Application
  • Revenue Forecast by Application
  • Revenue Forecast Discussion by Application

5. Market Share and Competitive Analysis – Total BAS Market

  • Market Share
  • Market Share Analysis
  • Competitive Environment

6. Growth Opportunities and Companies to Action

  • Top 4 Growth Opportunities in the European BAS Market
  • Growth Opportunity 1 – Innovation Scouting
  • Growth Opportunity 2 – IoT-enabled Solutions
  • Growth Opportunity 3 – Intelligent PAAS Solutions
  • Growth Opportunity 4 – Integration of Product Lines
  • Strategic Imperatives for Success and Growth

7. Market Analysis – Germany

8. Market Analysis – UK

9. Market Analysis – Italy

10. Market Analysis – Iberia

11. Market Analysis – France

12. Market Analysis – Benelux

13. Market Analysis – Nordic Region

14. Market Analysis – Rest of Europe (RoE)

15. The Last Word

  • The Last Word – 3 Big Predictions

16. Appendix

  • Market Engineering Methodology
  • Abbreviations and Acronyms
  • List of Companies in Others
  • List of Exhibits

For more information about this report visit https://www.researchandmarkets.com/r/l5uf6p

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/europes-building-automation-systems-market-2018-2019–2025f—innovation-scouting-iot-enabled-solutions-intelligent-paas-solutions–integration-of-product-lines-present-growth-opportunities-300962261.html

SOURCE Research and Markets

Exiger’s DDIQ Wins RegTech Solution of the Year for Second Time

Canadian FinTech and AI Awards Recognize Exiger as Innovation Leader

NEW YORK and TORONTO, Nov. 21, 2019 /PRNewswire/ — Exiger, the global leader in tech-enabled financial crime, risk and compliance solutions, has won the 2019 Canadian FinTech and AI Award for RegTech Solution of the Year. Exiger was recognized as the leader in the development and deployment of innovative artificial intelligence (AI) powered solutions for financial institutions, multinational corporations and government agencies.

Exiger's DDIQ team accepts RegTech Solution of the Year at the 5th Annual Canadian Fintech & AI Awards 2019

“We’re thrilled to win this award distinguishing Exiger for its role in advancing industry-leading solutions that help our clients drive more sustainable compliance in a complex and rapidly evolving business and regulatory landscape,” said Alex Ceponkus, Global Head of Software Engineering at Exiger.

The RegTech Solution of the Year distinction is awarded to the company that best demonstrates a material impact on regulatory compliance through technology and responsible innovation. For the second time, Judges selected Exiger’s DDIQ, the AI-powered automated due diligence and investigative platform.

“The Digital Finance Institute’s Awards recognize innovators in financial services and AI who are helping to promote Canada as a leading hub for technology innovation and research,” said Ellis Odynn, Executive Director of Digital Finance Institute.

Built with proprietary AI technology and trained by former compliance practitioners, DDIQ is transforming how some of the world’s largest organizations tackle their biggest compliance challenges by using AI to read, understand and analyze content with the same approach and cognitive reasoning as an industry expert. The technology dramatically reduces false positives and allows human reviewers to focus on only the most relevant and analytical tasks.

“Over the past six years, Exiger has continuously invested in the people and capabilities needed to build and implement truly transformative technology. Receiving this award for the second time is a validation of our team’s consistent efforts to provide clients with the most efficient and effective solutions available in the market,” said Michael Cherkasky, Exiger Executive Chairman.

The winners were announced at an Awards Gala on November 18, 2019, at the Royal York Hotel, with judges from leading organizations including Credit Suisse, the World Bank, Rolls-Royce, NASA, Lloyd’s Bank, Amazon, Standard Chartered Bank, Airbnb, Hulu, Google, Cineplex, and LG Electronics.

This is the third global award Exiger has received in recent months. In September, the company won the 2019 Central Banking FinTech & RegTech Global Award in the Anti-Money Laundering Technology (AML) Provider category. Earlier this month, Exiger won in the Best Solution Provider category for AML/Counter Terrorist Financing (CTF) compliance at the 2019 Regulation Asia Awards for Excellence.

About Exiger

Exiger is the global authority on financial crime and risk compliance introducing technology-enabled solutions to the market’s biggest compliance challenges. Exiger is changing the way banks, corporations and governmental agencies fight financial crime by combining industry expertise and artificial intelligence to root out bribery, corruption, sanctions violations, money laundering and terrorist financing. In recognition of the growing volume and complexity of data and regulations, Exiger is committed to working with clients to create a more sustainable compliance environment through its holistic and innovative approach to problem solving.  Powering its Advisory, Diligence and Government Services solutions, Exiger has developed purpose-built technology –– DDIQ and Insight 3PM –– trained and deployed by its subject matter experts to accelerate the auditability, efficiency, quality and cost effectiveness of clients’ compliance operations. Exiger operates in six countries and eight cities around the world, including London, New York City, the Washington, D.C. metro area, Toronto, Vancouver, Bucharest, Hong Kong and Singapore.

About the Digital Finance Institute (DFI)

The Digital Finance Institute is a think tank for financial technology, AI, law and innovation with three foundational pillars – financial inclusion, responsible innovation and supporting women in FinTech. Today, the Institute is run by Millennials, which we believe provides an important voice for leading Canada’s digital economy forward inclusively.

For the full list of Award winners, please visit http://www.fintechawards.org/winners/.

For more information, please contact info@digitalfinanceinstitute.org.

CONTACTS

U.S.
Kody Gurfein
+1 212 455 9408
kgurfein@exiger.com

Mark Pasetsky
+1 212 243 8543
mark@markallenco.com

Exiger

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/exigers-ddiq-wins-regtech-solution-of-the-year-for-second-time-300963214.html

SOURCE Exiger

Hyland Healthcare Advisory Councils Surface Top Tech Trends

CLEVELAND, Nov. 21, 2019 /PRNewswire/ — Hyland Healthcare, a leading provider of connected healthcare solutions for organizations across the globe, and three of the company’s advisory councils came together during Hyland’s annual user conference, CommunityLIVE, to discuss leading issues in healthcare IT. Major themes discussed reflect the most pressing needs and top trends in the industry, including cloud-hosted solutions, artificial intelligence (AI) and optimizing existing technology investments such as electronic health records (EHRs) and enterprise imaging systems. 

Hyland Software, Inc. Logo

The three advisory councils consist of Hyland Healthcare customers who represent large healthcare systems to small community hospitals, and utilize a variety of electronic medical records and other technology. Major trends identified across the groups include:

  • Cloud: as recently as last year, there was some interest in cloud, but now healthcare CIOs and CMIOs are exploring how soon they could get many of their applications into the cloud. This can mean an organization moves their entire infrastructure into their own cloud data center; uses a more public cloud but still handles all the management themselves; or leverages a privately-hosted solution like Hyland’s Global Cloud Services.

    Organizations are now more ready to adopt the cloud because of growing costs and liability with on premise solutions. Also, major ERP providers are increasingly moving to the cloud, which drives a need to have other enterprise software solutions in the same environments.

  • AI: The AI discussion in healthcare has long focused on clinical applications, but organizations now also recognize the benefit of machine learning and AI for operational and back office functions. There are many repetitive processes that can be automated, saving stretched office staff more time for critical thinking and exceptions. Solutions like Hyland’s new partnership with robotic process automation leader, Blue Prism can streamline activities like invoice processing and HR functions. Intelligent capture solutions like Brainware also offer machine learning to rapidly ingest, index and archive documents, making clinical or operational data readily available across healthcare organizations.
  • Optimization: healthcare organizations have made deep investments in legacy systems, such as EHRs, that often cannot and should not be immediately replaced. When upgrades are needed or better technologies become available, organizations need seamless integrations to optimize and enhance their functionality for years to come. For example, when organizations seek HIM optimization, integrating the scanning, extracting and indexing of external documents with existing systems is one way to add significant capabilities without overhauling the entire tech stack. Similarly, enterprise imaging solutions including vendor-neutral archives or universal viewers can also connect disparate imaging archives to make content available across departments.

“The importance of Hyland Healthcare’s advisory councils can’t be overstated. These knowledgeable professionals take time to share their day-to-day experiences and practical insights so our team can continue building software solutions that respond to real-world needs,” said Susan deCathelineau, senior vice president of global healthcare sales and services at Hyland. “It’s inspiring to hear from experts who interact with patients as well as those who manage the business side of healthcare organizations. We apply findings from our advisory councils to help all our customers address key initiatives like patient engagement and operational efficiencies to improve today’s healthcare delivery system.” 

For more information, visit HylandHealthcare.com.

About Hyland Healthcare
Hyland Healthcare provides connected healthcare solutions that harness unstructured content at all corners of the enterprise and link it to core clinical and business applications such as electronic medical records (EMR) and enterprise resource planning (ERP) systems. Hyland Healthcare is the only technology partner that offers a full suite of content services and enterprise imaging tools, bringing documents, medical images and other clinically rich data to the healthcare stakeholders that need it most. This comprehensive view of patient information accelerates business processes, streamlines clinical workflows and improves clinical decision making. For more information, visit hylandhealthcare.com. 

Media contact:
McKinzey Saig
+1 440-788-5082
McKinzey.Saig@hyland.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hyland-healthcare-advisory-councils-surface-top-tech-trends-300963177.html

SOURCE Hyland

The Pod by Eight Sleep Named to TIME’s List of the 100 Best Inventions of 2019

NEW YORK, Nov. 21, 2019 /PRNewswire/ — Today, TIME revealed the Pod by Eight Sleep has been selected as one of TIME’s 2019 Best Inventions. The annual list features the 100 best inventions that are making the world better, smarter and even a bit more fun. 

The Pod is the latest innovation by Eight Sleep, the sleep fitness company using technology to help people sleep better. Launched to great success in February of 2019, the Pod is the first bed to combine dynamic temperature regulation, biometric tracking, smart home integrations and sleep coaching to deliver a total solution for enhanced rest and recovery. Its most groundbreaking feature, dynamic temperature, includes artificial intelligence that learns sleep habits and adjusts the temperature in bed automatically. The feature was built using data and knowledge accumulated over the years as an industry leader, including more than 51 million hours of tracked sleep and a body of circadian rhythm research.

Within a few months of being on the market, the Pod has built a cult user base of business leaders, technology titans, venture capitalists, and high- performing athletes including Daryl Homer – Olympic Fencer, Ryan Lochte – Olympic Swimmer, Cassius Marsh – SF 49’ers, Mitchell Robinson – NY Knicks, Jarvis LandryCleveland Browns, Katie Boren – American Ballet Theatre, Matthew Dellavedova – Cleveland Cavaliers, and many more. 

“At Eight Sleep, we are building products that optimize sleep through technology, data, and insights. As a pioneer of the sleep fitness category, we are educating the world on what it means to be sleep fit, how to achieve it, how to measure it, and the benefits of it,” said Matteo Franceschetti, Co-Founder and CEO of Eight Sleep. “The Pod is a testament that technology, when properly used, has the power to unlock positive potential including, better rest for every individual. Five years from now, consumers will expect much more from their beds and products like the Pod are setting a new standard.”

The best-selling Eight Sleep Pod is available at eightsleep.com with pricing starting at $2,295 for a Full, $2,495 for Queen, $2,795 for King and California King. 

To assemble the 2019 TIME Best Inventions list, TIME solicited nominations across a variety of categories from editors and correspondents around the world, as well as through an online application process. Each contender was then evaluated on key factors, including originality, effectiveness, ambition, and influence. The result: 100 groundbreaking inventions that are changing the way we live, work, play and think about what’s possible. See the full list here: time.com/bestinventions2019 

About Eight Sleep

Eight Sleep is the world’s first sleep fitness brand with a mission to fuel human potential through optimal sleep. Founded in New York City in 2014, Eight Sleep leverages thermoregulation, data, and technology to design products to restore individuals to their peak energy levels every morning. Eight Sleep was named one of Fast Company’s “Most Innovative Companies” in 2018 and recognized by TIME’s “Best Inventions” for two consecutive years. Eight Sleep has raised $65M in funding from leading investors including Founders Fund, Khosla Ventures, Y Combinator, Craft Ventures, and 8VC. To learn more, visit eightsleep.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/the-pod-by-eight-sleep-named-to-times-list-of-the-100-best-inventions-of-2019-300963161.html

SOURCE Eight Sleep

Fujifilm Showcases Artificial Intelligence Initiative And Advances AI Education At RSNA 2019

LEXINGTON, Mass., Nov. 21, 2019 /PRNewswire/ — (Booth #4111) — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Informatics solutions, and part of the larger Fujifilm Healthcare portfolio, will showcase REiLI,* the company’s global Medical Imaging and Informatics Artificial Intelligence (AI) technology initiative at the Radiological Society of North America’s (RSNA) annual meeting to be held from December 1-5, 2019 at McCormick Place in Chicago, IL. At RSNA 2019, Fujifilm will also host a dynamic Lunch & Learn session focused on current clinical successes and future considerations for implementing AI into a radiologist’s workflow and daily practice. This educational event will be held on Monday, December 2, from 12:30 – 1:30pm CST in room S403A of McCormick Hall.

(PRNewsfoto/FUJIFILM Medical Systems U.S.A.)

“Fujifilm has a long and proven reputation as a trailblazer in medical imaging, and is committed to continuing to innovate and drive positive change in artificial intelligence,” said Takuya Shimomura, Chief Technology Officer and Executive Director, FUJIFILM Medical Systems U.S.A., Inc. “At RSNA 2019, we look forward to sharing the AI insights and advances we’ve made by working closely with clinical and research partners for several years. Ultimately, the long-term goal of our AI initiative is to help providers make better decisions that improve patient lives.”

Under the REiLI brand, Fujifilm is developing AI technologies that strongly support diagnostic imaging workflow, leveraging the combination of its deep learning innovations and distinct image processing heritage. Applications currently in development include, but are not limited to: Region Recognition, an AI technology that helps to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions; Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists’ clinical decision making; Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings, and report population automation. 

“Our latest Synapse 7x brings diagnostic radiology, mammography and cardiology together on the server-side, enabling immediate interaction with these modality imaging data sets through a single AI-enabled platform,” said Bill Lacy, Vice President, Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “We’re excited to debut this solution for our US customers at RSNA 2019, showing our commitment to progressing AI technology to empower physicians to make more efficient and impactful care decisions.”

RSNA attendees are encouraged to learn more about REiLI at Booth #4111 and participate in the following Fujifilm-hosted activities:

In-Booth Artificial Intelligence Lab
At booth #4111, attendees can visit Fujifilm’s AI Lab. The lab will feature dedicated workstations demonstrating REiLI use cases within Synapse PACS. Attendees can witness first-hand the speed and depth of the integrated workflows achieved by unifying Fujifilm’s REiLI technology with the company’s server-side PACS system.  Featured in the AI lab will be Fujifilm developed algorithms, to include CT lung nodule, intracerebral hemorrhage, cerebral infarction MR & CT, spine label and bone temporal subtraction to name a few. In addition to the Fujifilm AI development, the AI lab will showcase its strengths by supporting a multitude of integration points in support of partner vendor and provider developed algorithms. This will include Riverain’s lung nodule, MaxQ’s stroke, Lunit’s Chest & 2D Mammography, LPixel’s MR Aneurysm, Koios’ US breast, Aidoc’s pulmonary embolism and Gleamer’s bone fracture.

Lunch & Learn—”Putting AI Into Practice”
Hear from practicing radiologists, and those that support them, on how Artificial Intelligence (AI) is currently impacting their workflows, and what considerations they would recommend for future deployments. Led by Fujifilm’s Enterprise Imaging experts, this interactive panel will provide unprecedented insights around the real-world use cases of one of today’s most anticipated technologies.

This free event will take place on Monday, December 2, from 12:30-1:30 pm CST in room S403A of McCormick Hall.  Lunch will be served. To register, visit rsna.fujimed.com/lunch-learn-2019.

To learn more information, or book your RSNA demo with Fujifilm, visit rsna.fujimed.com.

*Fujifilm’s artificial intelligence software is a work in progress and is not commercially available in the United States.

About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions that meet the evolving needs of healthcare facilities both today and tomorrow. From an unrivaled selection of digital X-ray systems, to the comprehensive Synapse® Enterprise Imaging portfolio, to full-field digital mammography systems with digital breast tomosynthesis, and computed tomography solutions for oncology and radiology applications, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced endoscopic imaging solutions and devices to the medical field. Fujifilm’s TeraMedica Division, the leading provider of vendor neutral, enterprise-wide solutions for unrestricted me24dical image management and the core to the Synapse Enterprise Imaging portfolio, enables improved patient care by connecting imaging content across the entire care continuum. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation in Tokyo, Japan, brings innovative solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies derived from photographic film. Its proprietary core technologies contribute to the fields of healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.  For more information, please visit: www.fujifilmholdings.com.    

REiLI is Fujifilm's global Medical Imaging and Informatics Artificial Intelligence (AI) technology initiative

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/fujifilm-showcases-artificial-intelligence-initiative-and-advances-ai-education-at-rsna-2019-300963146.html

SOURCE FUJIFILM Medical Systems U.S.A., Inc.

Scientific Systems Receives DARPA Blackjack Pit Boss Prime Contract

WOBURN, Mass., Nov. 21, 2019 /PRNewswire/ — Scientific Systems Company, Inc. (SSCI) has been awarded a Defense Advanced Research Projects Agency (DARPA) prime contract to begin development of the Pit Boss mission system for the Blackjack satellite constellation. The DARPA Blackjack program aims to demonstrate the capabilities of a proliferated low Earth orbit (P-LEO) system through a variety of on-orbit experiments using 20 low-cost small satellites, each carrying payloads relevant to select military missions. Pit Boss is the computing and encryption hardware and modular software element of Blackjack that is envisioned to enable autonomous on-orbit mission tasking, sensor collection, on-board processing and exploitation, and dissemination via a worldwide digital network, all at mission speed. The Pit Boss ground segment will be designed to be relatively simple compared to those in use today. It should provide the powerful ability of large numbers of military users – on the ground, in the air, or at sea – to request specific payload data services from the constellation with the ease of a typical internet commercial sales transaction. Pit Boss further should provide an open and cyber-resilient platform architecture that allows the flexible and rapid integration of new mission payloads and autonomy software applications onto a commoditized small satellite bus of choice.

SSCI leads an expert development team that includes Oxford Systems, Emergent Space Technologies, Orbit Logic, Raytheon BBN Technologies, Raytheon Space and Airborne Systems, DZYNE, Kitware, Leaf Labs, Dornerworks, and Innoflight.  SSCI Vice President of Research and Development, Dr. Owen Brown, provides insight into the company’s approach to solve this challenging problem: “We are leveraging our Collaborative Mission Autonomy (CMA) software platform for Pit Boss. CMA brings to the Space Domain what our national security space users need: flexibility, resiliency, and a significant increase in both acquisition and operational responsiveness. This is the same software platform we have utilized for solving similar problems for distributed autonomy, at scale, in the Maritime and Air Domains. We look forward to demonstrating how CMA in space can radically improve how warfighters get the information they need when they need it.”  Raman Mehra, the CEO of SSCI adds, “This is a significant award in the history of SSCI. We are excited to be given the chance to create a capability that will be of great benefit to our country’s national security. I’m proud of our Pit Boss team, which represents the ecosystem of developers required to implement, sustain, and evolve space-based capabilities at a time constant required to stay ahead of our adversaries.”

About Scientific Systems Company Inc.

Since 1976, Scientific Systems Company Inc. (SSCI) has been developing the brains and nervous system for manned and unmanned vehicles to operate autonomously and accomplish their missions in difficult environments for defense and commercial applications. Based in Woburn, MA, SSCI is a leading innovator in performing research and technology development for NASA and US DoD agencies. SSCI is a provider of artificial intelligence-enabled autonomous software systems for land, sea, air, and space systems, GPS-denied navigation systems, and mission planning systems. In short – SSCI provides autonomy for any mission.  For more information, visit www.ssci.com or contact SSCI at (781) 933-5355 or info@ssci.com.

DISTRIBUTION A. Approved for Public Release, Distribution Unlimited

Cision View original content:http://www.prnewswire.com/news-releases/scientific-systems-receives-darpa-blackjack-pit-boss-prime-contract-300963111.html

SOURCE Scientific Systems Company Inc.

Fujifilm Presents Research & Development Advancements In AI For Digital Radiography At RSNA

LEXINGTON, Mass., Nov. 21, 2019 /PRNewswire/ — (Booth #4111) – FUJIFILM Medical Systems U.S.A., Inc.  a leading provider of diagnostic imaging products and medical informatics solutions, and part of the Fujifilm Healthcare portfolio, will present research and development advancements in Artificial Intelligence (AI)* for digital radiography at McCormick Place in Chicago during the 105th scientific assembly and annual meeting of the Radiological Society of North America (RSNA) from December 1 – 6, 2019.

(PRNewsfoto/FUJIFILM Medical Systems U.S.A.)

“AI has the potential to bring a wealth of advancements to the medical imaging community,” said Gregg R. Cretella, Director, Strategic Innovation, Modality Solutions, FUJIFILM Medical Systems U.S.A., Inc. “Fujifilm will showcase image processing technologies and the practical application of AI technologies to support diagnostic imaging and medical workflow. Combining AI technology with digital radiography can help identify surgical hardware and suspect findings. The technology can also position patients properly during exams. These advancements are designed to save valuable time, prevent exam retakes and speed clinician workflow.”

Fujifilm continues to develop AI technologies that have the potential to support diagnostic imaging workflow, leveraging the combination of deep learning in its AI technology with Fujifilm’s image processing heritage. 

At RSNA, Fujifilm will demonstrate how its AI platform can be used in the Emergency Room, Operating Room and during general X-ray exams. Through these demonstrations, RSNA attendees will have the opportunity to witness how AI will influence the future of radiography.

Artificial Intelligence in the Emergency Room
AI in the ER will be demonstrated on the FDR AQRO mini mobile DR system*. AI-powered recognition algorithms could provide indications to physicians of suspicious findings. AI recognition will search and map images to help identify pathologies such as pneumothorax and more.

Artificial Intelligence in the Operating Room
AI in the OR will be demonstrated on the FDX Console*, which has the ability to be paired with Fujifilm mobile systems. The intelligent feature and density recognition are designed to highlight foreign objects such as surgical gauze for images acquired during or post-surgery.

Artificial Intelligence during General X-ray Exams
AI for positioning navigation will be demonstrated with a camera built into the collimator of a Fujifilm X-ray room. The system will match the exam menu selected for proper patient positioning and check for expected anatomy and/or anatomy orientation prior to exposure.

For more information about Fujifilm at RSNA or to schedule a product demonstration, please visit https://rsna.fujimed.com.

* Fujifilm AI integration for digital X-ray is in development and is not yet commercially available.

About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions that meet the evolving needs of healthcare facilities both today and tomorrow. From an unrivaled selection of digital X-ray systems (DR: detectors, mobiles, and rooms), to the comprehensive Synapse® Enterprise Imaging portfolio, to full-field digital mammography systems with digital breast tomosynthesis, and computed tomography solutions, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced endoscopic imaging solutions and devices to the medical field. Fujifilm’s TeraMedica Division, the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management and the core to the Synapse Enterprise Imaging portfolio, enables improved interoperability by connecting imaging content across the entire care continuum. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

All product and company names herein may be trademarks of their registered owners.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/fujifilm-presents-research–development-advancements-in-ai-for-digital-radiography-at-rsna-300963113.html

SOURCE FUJIFILM Medical Systems U.S.A., Inc.

Automation Anywhere Announces $290 Million in Series B Financing

SAN JOSE, Calif., Nov. 21, 2019 /PRNewswire/ — Automation Anywhere, a global leader in Robotic Process Automation (RPA), announced that it has received $290 million in Series B funding at a post money valuation of $6.8 billion. The funding was led by Salesforce Ventures with additional funding from existing investors, including SoftBank Investment Advisers and Goldman Sachs.

(PRNewsfoto/Automation Anywhere)

The new capital will help Automation Anywhere accelerate its vision to empower customers to automate end-to-end business processes – bridging the gap between the front and back office with an artificial intelligence (AI) powered intelligent automation platform. In addition, the funding will advance the company’s focus on improving human-to-bot collaboration through attended automation, resulting in enhanced customer experiences and increased employee productivity.

A year ago, Automation Anywhere announced its Series A investment of $550 million from SoftBank Investment Advisers, General Atlantic, Goldman Sachs, NEA, World Innovation Lab, and Workday Ventures. The latest funding from Salesforce Ventures and other investors is a testament to Automation Anywhere’s leadership in this sector.

Driven by digital transformation, RPA has become the fastest growing enterprise software category, according to Gartner, Inc.

“Never before has there been such a transformative shift in the way we work, with artificially intelligent software bots changing how people, processes and technology interact for productivity gains,” said Mihir Shukla, CEO and co-founder, Automation Anywhere. “This new funding reinforces the promise of the RPA category and empowers our customers to achieve greater business agility and increased efficiencies by automating end-to-end business processes – bridging the gap between the front and back office.”

The company launched its Automation Anywhere Salesforce Connector on Salesforce AppExchange, the world’s leading enterprise cloud marketplace, bringing its market-leading intelligent automation platform to Salesforce global users through pre-built software bots. This will, for example, empower a customer service agent to get help from an attended RPA bot during a live customer call, improving both the agent’s productivity and the customer experience.

“Automation Anywhere makes it easier for Salesforce customers to automate repetitive, manual tasks and focus on what matters most—the customer,” said Bill Patterson, Executive Vice President and General Manager, Salesforce Service Cloud. “We’re excited to extend our partnership with Automation Anywhere to help more customers automate their end-to-end business processes and accelerate their digital transformation journeys.”

Interact with Automation Anywhere:

About Automation Anywhere
Automation Anywhere is a global leader in Robotic Process Automation (RPA), empowering customers to automate end-to-end business processes with software bots – digital workers that perform repetitive and manual tasks, resulting in dramatic productivity gains, improved customer experience and more engaged employees. The company offers the world’s only web-based and cloud native intelligent automation platform combining RPA, artificial intelligence, machine learning and analytics right out of the box, to help organizations rapidly start and scale their process automation journey. With offices in more than 40 countries and a global network of 1,200 partners, Automation Anywhere has deployed over 1.7 million bots to support some of the world’s largest enterprises across all industries. For additional information, visit www.AutomationAnywhere.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/automation-anywhere-announces-290-million-in-series-b-financing-300962896.html

SOURCE Automation Anywhere

Global DevOps Market by Type, Deployment Model, Organization Size, Tools, Industry Vertical & Region – Forecast to 2024

DUBLIN, Nov. 21, 2019 /PRNewswire/ — The “DevOps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The global DevOps market was worth US$ 3.5 Billion in 2018. Looking forward, the market is forecast to reach a value of US$ 10.5 Billion by 2024, registering a CAGR of around 20% during 2019-2024.

Various organizations and industries ranging from shopping to entertainment to banking are shifting toward automated software deployment, which is more accurate, practical and involves low maintenance costs as compared to manual procedures.

Besides this, the emerging trends of Artificial Intelligence (AI) and Machine Learning (ML) are also providing a positive thrust to the market. AI and ML process vast amounts of information and help perform menial tasks, permitting the IT staff to do more targeted work and allowing them to learn patterns, anticipate problems and suggest solutions.

Further, increasing adoption of agile frameworks and cloud technologies, and digitization of enterprises to automate business processes are some of the other factors driving the growth of the market across the globe. Moreover, with the rapid penetration of Internet-of-Things (IoT), DevOps has gained popularity due to the co-dependence of the hardware and the embedded software that runs on it.

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being IBM, Microsoft, Oracle, CA Technologies, Google, Cisco Systems, Amazon Web Services, Cigniti Technologies, Hewlett Packard Enterprise Company, EMC Corporation, VersionOne, Micro Focus, Puppet, Red Hat, GitLab, Chef Software, Docker Inc., Atlassian, etc.

Key Questions Answered in This Report

  • How has the global DevOps market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global DevOps industry?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the deployment model?
  • What is the breakup of the market based on the organization size?
  • What is the breakup of the market based on the tools?
  • What is the breakup of the market based on the industry vertical?
  • What are the various stages in the value chain of the global DevOps industry?
  • What are the key driving factors and challenges in the global DevOps industry?
  • What is the structure of the global DevOps industry and who are the key players?
  • What is the degree of competition in the global DevOps industry?

Key Topics Covered

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global DevOps Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Type
5.4 Market Breakup by Deployment Model
5.5 Market Breakup by Organization Size
5.6 Market Breakup by Tools
5.7 Market Breakup by Industry Vertical
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Type
6.1 Solutions
6.2 Services

7 Market Breakup by Deployment Model
7.1 Public Cloud
7.2 Private Cloud
7.3 Hybrid Cloud

8 Market Breakup by Organization Size
8.1 Large Enterprises
8.2 Medium-Sized Enterprises
8.3 Small-Sized Enterprises

9 Market Breakup by Tools
9.1 Development Tools
9.2 Testing Tools
9.3 Operation Tools

10 Market Breakup by Industry Vertical
10.1 Telecommunications and Information Technology Enabled Services (ITES)
10.2 Banking, Financial Services, and Insurance (BFSI)
10.3 Retail
10.4 Manufacturing
10.5 Healthcare
10.6 Government and Public Sector
10.7 Others

11 Market Breakup by Region
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 Latin America

12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 IBM
16.3.2 Microsoft
16.3.3 Oracle
16.3.4 CA Technologies
16.3.5 Google
16.3.6 Cisco Systems
16.3.7 Amazon Web Services
16.3.8 Cigniti Technologies
16.3.9 Hewlett Packard Enterprise Company
16.3.10 EMC Corporation
16.3.11 VersionOne
16.3.12 Micro Focus
16.3.13 Puppet
16.3.14 Red Hat
16.3.15 GitLab
16.3.16 Chef Software
16.3.17 Docker Inc.
16.3.18 Atlassian

For more information about this report visit https://www.researchandmarkets.com/r/92gnau

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-devops-market-by-type-deployment-model-organization-size-tools-industry-vertical–region—forecast-to-2024-300962216.html

SOURCE Research and Markets